CID 155309155

Lirafugratinib

Structural Information

Molecular Formula
C28H24FN7O2
SMILES
CC1=NC(=NC=C1)OC2=C(C=C(C=C2)C3=C(N(C4=NC=NC(=C34)N)C)C5=CC=C(C=C5)NC(=O)C(=C)C)F
InChI
InChI=1S/C28H24FN7O2/c1-15(2)27(37)35-19-8-5-17(6-9-19)24-22(23-25(30)32-14-33-26(23)36(24)4)18-7-10-21(20(29)13-18)38-28-31-12-11-16(3)34-28/h5-14H,1H2,2-4H3,(H,35,37)(H2,30,32,33)
InChIKey
XOQVZSSDIQQUGO-UHFFFAOYSA-N
Compound name
N-[4-[4-amino-5-[3-fluoro-4-(4-methylpyrimidin-2-yl)oxyphenyl]-7-methylpyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-methylprop-2-enamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

3
References

87
Patents

509.19754 Da
Monoisotopic Mass

4.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 510.20482 224.9
[M+Na]+ 532.18676 240.4
[M+NH4]+ 527.23136 228.2
[M+K]+ 548.16070 235.1
[M-H]- 508.19026 230.1
[M+Na-2H]- 530.17221 233.2
[M]+ 509.19699 228.4
[M]- 509.19809 228.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe